Published by
@ShahidNShah
@ShahidNShah
March 7 to March 9, 2023
Hilton Boston Back Bay 40 Dalton St Boston, MA 02115 United States
The demand for cell and gene therapies is growing at an exponential rate as an increasing number of drug developers scale up their supply chain operations as their pipelines grow and more candidates are accelerated into the clinic.
As numerous therapies progress to commercial levels, there has never been a more important time to synergize your supply and clinical efforts to future-proof the scalability, accessibility and patient-centricity of your cell or gene therapy treatment, particularly in an acute period of geopolitical global disruption.
Continue reading at supply-cell-immunotherapy.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 19, 2024 at 8:35am